Anti-Human IL13 Therapeutic Antibody (Lebrikizumab)
Recombinant monoclonal antibody to IL13. Lebrikizumab (INN) is a humanized monoclonal antibody and an experimental immunosuppresive drug for the treatment of asthma that cannot be adequately controlled with inhalable glucocorticoids.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-219 |
| Pricing | Inquiry |
| Host | undefined |
| Target | IL13 |
| Species Reactivity | Human |
| Type | IgG4 - kappa |
| Applications | Neut, IF, IP, FC, FuncS, ELISA, PK, Block |
| Storage | Store at -20°C for long-term storage. Store at 2-8°C for up to one month. Avoid freeze/thaw cycles. |